Publications by authors named "Esther Schuler"

Claim this Profile
C
Clinical and Cytogenetic Characterization of Early and Late Relapses in Patients Allografted for Myeloid Neoplasms with a Myelodysplastic Component.
Victoria Platte, Anika Bergmann, Barbara Hildebrandt, Dagmar Wieczorek, Esther Schuler

Cancers (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of the Peritoneal Cancer Index (PCI) to predict surgical outcome after neoadjuvant chemotherapy in advanced ovarian cancer.
Friederike Luise Rawert, Veronica Luengas-Würzinger, Sabrina Claßen-Gräfin von Spee, Saher Baransi, Esther Schuler

Arch Gynecol Obstet· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities and Limitations of Pelvic Exenteration Surgery.
Björn Lampe, Verónica Luengas-Würzinger, Jürgen Weitz, Stephan Roth, Friederike Rawert, Esther Schuler

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the Cardiophrenic Lymph Node Status After Neoadjuvant Chemotherapy in Primary Advanced Ovarian Cancer.
Veronica Luengas-Wuerzinger, Friederike Rawert, Sabrina CLAßEN-VON Spee, Saher Baransi, Esther Schuler

Anticancer Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eligibility for clinical trials is unsatisfactory for patients with myelodysplastic syndromes, even at a tertiary referral center.
Kathrin Nachtkamp, Josefine Stark, Andrea Kündgen, Thomas Schroeder, Corinna Strupp, Esther Schuler

Leuk Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
Esther Schuler, Eva-Maria Wagner-Drouet, Salem Ajib, Gesine Bug, Martina Crysandt

Ann Hematol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q).
Anna Hecht, Julia A Meyer, Johann-Christoph Jann, Katja Sockel, Aristoteles Giagounidis, Esther Schuler

Ann Hematol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
Esther Schuler, Eva-Maria Wagner-Drouet, Salem Ajib, Gesine Bug, Martina Crysandt

Ann Hematol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the accuracy of prognostication in chronic myelomonocytic leukemia.
Jennifer Kaivers, Esther Schuler, Barbara Hildebrandt, Beate Betz, Christina Rautenberg

Expert Rev Anticancer Ther· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Response and Survival Following Treatment with Azacitidine for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation.
Christina Rautenberg, Anika Bergmann, Ulrich Germing, Caroline Fischermanns, Sabrina Pechtel, Esther Schuler

Cancers (Basel)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Value of Torque Teno Virus (TTV) as a Marker for the Degree of Immunosuppression in Adult Patients after Hematopoietic Stem Cell Transplantation (HSCT).
Julia Schmitz, Guido Kobbe, Mustafa Kondakci, Esther Schuler, Max Magorsch

Biol Blood Marrow Transplant· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison between Upfront Transplantation and different Pretransplant Cytoreductive Treatment Approaches in Patients with High-Risk Myelodysplastic Syndrome and Secondary Acute Myelogenous Leukemia.
Thomas Schroeder, Nadija Wegener, Michael Lauseker, Christina Rautenberg, Kathrin Nachtkamp, Esther Schuler

Biol Blood Marrow Transplant· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients.
Tobias Silzle, Sabine Blum, Esther Schuler, Jennifer Kaivers, Martina Rudelius

Blood Cancer J· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapse patterns and treatment strategies in patients receiving allogeneic hematopoietic stem cell transplantation for myeloid malignancies.
Esther Schuler, Sarah Boughoufala, Christina Rautenberg, Kathrin Nachtkamp, Ariane Dienst

Ann Hematol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation.
Mareike Frick, Willy Chan, Christopher Maximilian Arends, Raphael Hablesreiter, Adriane Halik, Esther Schuler

J Clin Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome of high risk patients with myelodysplastic syndromes or secondary acute myeloid leukemia receiving intensive chemotherapy.
Esther Schuler, Natalie Zadrozny, Sabine Blum, Thomas Schroeder, Corinna Strupp

Ann Hematol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial.
Friederike Braulke, Xenia Schulz, Ulrich Germing, Esther Schuler, Uwe Platzbecker

Ann Hematol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia.
Chiara Elena, Anna Gallì, Esperanza Such, Manja Meggendorfer, Ulrich Germing, Esther Schuler

Blood· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calreticulin mutations are not present in patients with myeloproliferative chronic myelomonocytic leukemia.
Lurdes Zamora, Ulrich Germing, Marta Cabezón, Esther Schuler, Montserrat Arnan

Ann Hematol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete genome sequence of Desulfohalobium retbaense type strain (HR(100)).
Stefan Spring, Matt Nolan, Alla Lapidus, Tijana Glavina Del Rio, Alex Copeland

Stand Genomic Sci· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reclassification of Desulfotomaculum auripigmentum as Desulfosporosinus auripigmenti corrig., comb. nov.
Erko Stackebrandt, Peter Schumann, Esther Schüler, Hans Hippe

Int J Syst Evol Microbiol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis